Glenmede Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-833
| Closed | -$274K | – | 1381 |
|
|
2024
Q4 | $274K | Sell |
833
-217
| -21% | -$71.3K | ﹤0.01% | 1131 |
|
|
2024
Q3 | $351K | Buy |
+1,050
| New | +$351K | ﹤0.01% | 1047 |
|
|
2020
Q4 | – | Sell |
-32
| Closed | -$15K | – | 1323 |
|
|
2020
Q3 | $15K | Buy |
32
+5
| +19% | +$2.34K | ﹤0.01% | 1709 |
|
|
2020
Q2 | $11K | Sell |
27
-2,373
| -99% | -$967K | ﹤0.01% | 1815 |
|
|
2020
Q1 | $888K | Hold |
2,400
| – | – | ﹤0.01% | 764 |
|
|
2019
Q4 | $888K | Buy |
+2,400
| New | +$888K | ﹤0.01% | 764 |
|
|
2017
Q4 | – | Sell |
-554
| Closed | -$122K | – | 2674 |
|
|
2017
Q3 | $122K | Sell |
554
-752
| -58% | -$166K | ﹤0.01% | 1369 |
|
|
2017
Q2 | $260K | Hold |
1,306
| – | – | ﹤0.01% | 1124 |
|
|
2017
Q1 | $260K | Hold |
1,306
| – | – | ﹤0.01% | 1124 |
|
|
2016
Q4 | $237K | Hold |
1,306
| – | – | ﹤0.01% | 1160 |
|
|
2016
Q3 | $213K | Hold |
1,306
| – | – | ﹤0.01% | 1175 |
|
|
2016
Q2 | $186K | Hold |
1,306
| – | – | ﹤0.01% | 1198 |
|
|
2016
Q1 | $177K | Hold |
1,306
| – | – | ﹤0.01% | 1193 |
|
|
2015
Q4 | $181K | Hold |
1,306
| – | – | ﹤0.01% | 1198 |
|
|
2015
Q3 | $174K | Hold |
1,306
| – | – | ﹤0.01% | 1210 |
|
|
2015
Q2 | $195K | Sell |
1,306
-269
| -17% | -$40.2K | ﹤0.01% | 1227 |
|
|
2015
Q1 | $212K | Hold |
1,575
| – | – | ﹤0.01% | 1226 |
|
|
2014
Q4 | $189K | Sell |
1,575
-21
| -1% | -$2.52K | ﹤0.01% | 1321 |
|
|
2014
Q3 | $180K | Buy |
1,596
+21
| +1% | +$2.37K | ﹤0.01% | 1210 |
|
|
2014
Q2 | $188K | Hold |
1,575
| – | – | ﹤0.01% | 1192 |
|
|
2014
Q1 | $201K | Hold |
1,575
| – | – | ﹤0.01% | 1172 |
|
|
2013
Q4 | $194K | Hold |
1,575
| – | – | ﹤0.01% | 1165 |
|
|
2013
Q3 | $185K | Hold |
1,575
| – | – | ﹤0.01% | 1153 |
|
|
2013
Q2 | $176K | Buy |
+1,575
| New | +$176K | ﹤0.01% | 1123 |
|